The Negative Consequences of Contraceptive Birth Control (Essay Sample)

A rapid increase in population causes additional strain on the available scarce resources and to control population growth; governments have invested heavily in birth control campaigns where they emphasize on the importance of birth control methods such as the use of contraceptives and condoms. According to Petitti, more than 500 million people worldwide use hormonal contraceptives to date (29). Notably, In the US, the Hormonal contraceptive pill was introduced in the early 1960s (Welling 718). Keyes et al. (1378), report that 80% of the young women who are sexually active in the US use hormonal contraceptives. This high number of young women using contraceptives has been mainly due to improvements in sex education programs (Mauldon, and Luker 19). Doctors also significantly influence women's choice of the appropriate contraceptive method (Johnson et al. 1). For women, they are likely to suggest the contraceptive pill because it is a reliable method in preventing pregnancy. However, this paper takes the stance that contraceptive pills can have a myriad of negative consequences on the human body. Contraceptives can be effective and have minimal side effects only if the dose for estrogen is below 50 µg. Decreasing estrogen content in the contraceptives by 15% will ensure more positive results than the negative ones. Although oral contraceptives prevent pregnancies, dosages should be decreased because the hormones can result in cardiovascular disease, neoplastic disease, and metabolism defects.
Firstly, oral contraceptives (OCs) increase the risk of cardiovascular diseases. According to Roos-Hesselink, Cornette, Sliwa, Pieper, Veldtman, and Johnson, about 38% of 1321 of women using contraceptives are highly vulnerable to cardiovascular diseases (1728). It is a prevalent leather disorder which affects hospitalized as well as nonhospitalized patients. It is caused by too much ethinylestradiol dose which is an estrogen compound found in the OC. The risk of the disease occurs when ethinylestradiol dose exceeds 150µg (Stegeman et al. 2). According to Vinogradova et al., patients diagnosed with VTE can be treated using the anticoagulant mediation (12).